Suzuki, Misa
Nagai, Norihiro
Minami, Sakiko
Kurihara, Toshihide
Kamoshita, Mamoru
Sonobe, Hideki
Watanabe, Kazuhiro
Shinoda, Hajime
Tsubota, Kazuo
Ozawa, Yoko http://orcid.org/0000-0003-4797-5705
Article History
Received: 30 July 2019
Revised: 11 September 2019
Accepted: 20 September 2019
First Online: 15 November 2019
Compliance with ethical standards
:
: MS has received a speaker honorarium from Novartis Pharmaceuticals Japan. TK has received grants from Tsubota Laboratory, Inc., Fuji Xerox Co., Ltd., SEED Co., Ltd., Kowa Company, Santen Pharmaceutical Co. Ltd., and ROHTO Pharmaceutical Co., Ltd.; grants and speaker honorariums from Novartis Pharmaceuticals Japan; and personal fees from Bayer Yakuhin, Ltd.; all of these grants, honorariums, and fees were outside of the scope of the submitted work. KT reports research funding and consultancies from Santen Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co., Ltd., and Wakamoto Pharmaceutical Co., Ltd.; patents with JINS, Inc., Echo Electricity Co., and Kowa Company; KT is also the CEO of Tsubota Laboratory, Inc.; all of these grants, consultancies, patents, and employment arrangements were outside of the scope of the submitted work. YO received grants and speaker honorariums from Santen Pharmaceutical Co. Ltd., Novartis Pharmaceuticals Japan, Bayer Yakuhin, Ltd., Nitto Medic, Co. Ltd., Wakasa Seikatsu, Co. Ltd.; all of these grants and honorariums were outside of the scope of the submitted work. NN, SM, MK, HS, KW, and HS declare that they have no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Keio University School of Medicine, Tokyo, Japan, and were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.